API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://timesofindia.indiatimes.com/city/hyderabad/dr-reddys-lab-ties-up-with-pharmazz-to-market-centhaquine/articleshow/108723906.cms
https://www.globenewswire.com/news-release/2024/03/22/2850876/0/en/Pharmazz-Inc-and-Dr-Reddy-s-Laboratories-have-entered-into-a-licensing-agreement-to-market-Centhaquine-Lyfaquin-as-a-resuscitative-agent-for-hypovolemic-shock-in-India.html
https://www.globenewswire.com/news-release/2022/09/13/2514839/0/en/Pharmazz-Inc-Presents-Data-From-its-Positive-Phase-III-Study-of-Centhaquine-PMZ-2010-as-a-Resuscitative-Agent-in-Hypovolemic-Shock-Patients-at-Upcoming-Military-Health-System-Resea.html
https://www.prnewswire.com/news-releases/marketing-authorization-received-for-lyfaquin-centhaquine-to-treat-patients-with-hypovolemic-shock-from-indian-regulatory-agency-301059610.html